The report, published Tuesday by Stericycle ExpertSolutions, revealed trends in recalls across various sectors including pharmaceuticals and medical device.
Here are 10 other findings from the report.
Pharmaceuticals
- Seventy-nine percent of pharmaceutical recalls in the second quarter of 2016 were nationwide recalls.
- Fourteen companies experienced more than one pharmaceutical recall in the second quarter of 2016, the highest level in a quarter since the second quarter of 2015.
- The number of pharmaceutical units recalled in the second quarter of 2016 rose 169 percent compared to the previous quarter.
- Nearly 70 percent of recalled pharmaceutical units in the second quarter of 2016 were due to failed specifications.
- Sixty-six percent of recalled pharmaceutical units in the second quarter of 2016 were Class II, resuming a historical trend after a lower than average first quarter of 2016, when Class II accounted for 33 percent of recalled units.
Medical device
- The rate of recalled medical device units was three times higher in the second quarter of 2016, but was still 30 percent below the quarterly average in 2015.
- Nearly all (99 percent) of recalled medical device units in the second quarter of 2016 were considered Class II.
- Based on medical device recalls in the second quarter of 2016, the top three causes of these recalls were software, mislabeling and quality issues, making up a combined 51 percent of recalls.
- Nearly 90 percent of medical device recalled units in the second quarter of 2016 were recalled due to quality issues regarding specification and sterility concerns.
- Forty-nine percent of medical device unit recalls in the second quarter of 2016 were international, the lowest level since the fourth quarter of 2013.
More articles on supply chain:
Medical device industry agrees to FDA’s device user fees to raise regulatory funding
3 things to know about the US’ potential flu vaccination shortage
FDA: Drug companies abuse citizen petitions to block generic competition
